ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,930 | +295.0% | 14,947 | +658.7% | 0.00% | – |
| Q2 2023 | $8,589 | +11352.0% | 1,970 | -88.2% | 0.00% | -100.0% |
| Q1 2023 | $75 | -62.7% | 16,746 | -29.9% | 0.00% | -75.0% |
| Q4 2022 | $201 | -99.9% | 23,887 | +0.9% | 0.01% | +300.0% |
| Q3 2022 | $145,000 | +383.3% | 23,683 | +150.8% | 0.00% | +100.0% |
| Q2 2022 | $30,000 | +328.6% | 9,444 | +687.0% | 0.00% | – |
| Q1 2022 | $7,000 | -92.1% | 1,200 | -86.8% | 0.00% | -100.0% |
| Q4 2021 | $89,000 | -46.7% | 9,117 | +475.6% | 0.00% | -50.0% |
| Q3 2021 | $167,000 | -64.5% | 1,584 | -71.2% | 0.00% | -66.7% |
| Q2 2021 | $470,000 | +117.6% | 5,502 | +191.9% | 0.01% | +200.0% |
| Q1 2021 | $216,000 | +45.0% | 1,885 | +76.8% | 0.00% | -20.0% |
| Q4 2020 | $149,000 | +75.3% | 1,066 | +1.6% | 0.01% | +400.0% |
| Q3 2020 | $85,000 | -76.1% | 1,049 | -78.8% | 0.00% | -93.3% |
| Q2 2020 | $355,000 | +745.2% | 4,944 | +832.8% | 0.02% | +400.0% |
| Q3 2019 | $42,000 | +23.5% | 530 | -36.5% | 0.00% | +50.0% |
| Q1 2019 | $34,000 | -42.4% | 835 | -25.9% | 0.00% | -50.0% |
| Q4 2018 | $59,000 | +156.5% | 1,127 | +121.4% | 0.00% | +100.0% |
| Q3 2018 | $23,000 | – | 509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |